Article Versions Notes

Nakayama Y, Ando T, Takahashi N, Tsukada K, Takagi H, Goto Y, Nakaya A, Nakada N, Yoshita H, Motoo I, et al. The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis. Journal of Clinical Medicine. 2024; 13(3):834. https://doi.org/10.3390/jcm13030834

Nakayama, Yurika, Takayuki Ando, Naoki Takahashi, Kenichiro Tsukada, Hiroaki Takagi, Yuno Goto, Atsuko Nakaya, Naokatsu Nakada, Hiroki Yoshita, Iori Motoo, and et al. 2024. "The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis" Journal of Clinical Medicine 13, no. 3: 834. https://doi.org/10.3390/jcm13030834

Nakayama, Y., Ando, T., Takahashi, N., Tsukada, K., Takagi, H., Goto, Y., Nakaya, A., Nakada, N., Yoshita, H., Motoo, I., Ueda, A., Ueda, Y., Sakumura, M., Kajiura, S., Ogawa, K., Hosokawa, A., & Yasuda, I. (2024). The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis. Journal of Clinical Medicine, 13(3), 834. https://doi.org/10.3390/jcm13030834